Knockdown of MAGEA6 Activates AMP-Activated Protein Kinase (AMPK) Signaling to Inhibit Human Renal Cell Carcinoma Cells
Conclusion: MAGEA6 knockdown inhibits human RCC cells via activating AMPK signaling.Cell Physiol Biochem 2017;43:1205 –1218
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research
More News: Biochemistry | Cancer | Cancer & Oncology | Carcinoma | Cytology | Epithelial Cancer | Kidney Cancer | Melanoma | Physiology | Renal Cell Carcinoma | Skin Cancer | Study